Humanized antibodies that recognize alpha-synuclein
US8790644B2 · kind B2 · utility
21Cited by
10References
79Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 25, 2013 |
| Grant date | Jul 29, 2014 |
| Priority date | — |
| Expiry date | Jan 25, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application discloses humanized 1H7 antibodies. The antibodies bind to human alpha synuclein and can be used for treatment and diagnosis of Lewy body disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.